Niklas Pallmann, Elena Lajtha, Heike Oberwinkler, Tobias Weigel, Armin von Fournier, Agmal Scherzad, Jean-Marie Heydel, Stephan Hackenberg, Jochen Bodem, Maria Steinke
{"title":"Improving Human Respiratory Mucosa Tissue Models with Polyamide 6 Scaffolds.","authors":"Niklas Pallmann, Elena Lajtha, Heike Oberwinkler, Tobias Weigel, Armin von Fournier, Agmal Scherzad, Jean-Marie Heydel, Stephan Hackenberg, Jochen Bodem, Maria Steinke","doi":"10.1089/ten.tec.2025.0087","DOIUrl":null,"url":null,"abstract":"<p><p>Advanced tissue-engineered respiratory models are essential for studying drug or cosmetic toxicity, infection biology and xenobiotic metabolism. Here, we investigated a polyamide 6 (PA6)-based electrospun stromal scaffold as a substitute for porcine-derived small intestinal submucosa (SIS) to build human airway mucosa tissue models at the air-liquid interface. We demonstrate that the porous PA6 scaffold supports extracellular matrix production by human nasal fibroblasts and facilitates the complete differentiation of respiratory epithelial cells to the mucociliary phenotype. These models reduce reliance on animal-derived materials, improve reproducibility, and minimize potential interference from animal-derived antigens and pathogens. Both PA6- and SIS-based models promote fibroblast migration, epithelial differentiation, and the expression of key xenobiotic metabolizing enzymes. They exhibit comparable epithelial barrier integrity and susceptibility to influenza A virus infections. These findings establish PA6 scaffolds as a suitable, animal-free alternative to the SIS to build human airway mucosa tissue models.</p>","PeriodicalId":23154,"journal":{"name":"Tissue engineering. Part C, Methods","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tissue engineering. Part C, Methods","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/ten.tec.2025.0087","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0
Abstract
Advanced tissue-engineered respiratory models are essential for studying drug or cosmetic toxicity, infection biology and xenobiotic metabolism. Here, we investigated a polyamide 6 (PA6)-based electrospun stromal scaffold as a substitute for porcine-derived small intestinal submucosa (SIS) to build human airway mucosa tissue models at the air-liquid interface. We demonstrate that the porous PA6 scaffold supports extracellular matrix production by human nasal fibroblasts and facilitates the complete differentiation of respiratory epithelial cells to the mucociliary phenotype. These models reduce reliance on animal-derived materials, improve reproducibility, and minimize potential interference from animal-derived antigens and pathogens. Both PA6- and SIS-based models promote fibroblast migration, epithelial differentiation, and the expression of key xenobiotic metabolizing enzymes. They exhibit comparable epithelial barrier integrity and susceptibility to influenza A virus infections. These findings establish PA6 scaffolds as a suitable, animal-free alternative to the SIS to build human airway mucosa tissue models.
期刊介绍:
Tissue Engineering is the preeminent, biomedical journal advancing the field with cutting-edge research and applications that repair or regenerate portions or whole tissues. This multidisciplinary journal brings together the principles of engineering and life sciences in the creation of artificial tissues and regenerative medicine. Tissue Engineering is divided into three parts, providing a central forum for groundbreaking scientific research and developments of clinical applications from leading experts in the field that will enable the functional replacement of tissues.
Tissue Engineering Methods (Part C) presents innovative tools and assays in scaffold development, stem cells and biologically active molecules to advance the field and to support clinical translation. Part C publishes monthly.